THE SAFETY AND EFFICACY OF CONVERSION FROM CALCINEURIN INHIBITORS TO mTOR INHIBITORS IN STABLE KIDNEY TRANSPLANT RECIPIENTS

被引：0
|
作者：
Asanga, Abeyaratne [1 ]
Michael, Collins [1 ]
Kym, Bannister [1 ]
Graeme, Russ [1 ]
机构：
[1] Royal Adelaide Hosp, Renal & Transplantat Unit, Cent No Adelaide Renal & Transplantat Serv, Adelaide, SA, Australia
来源：
IMMUNOLOGY AND CELL BIOLOGY | 2012年 / 90卷 / 08期
关键词：
D O I：
暂无
中图分类号：
Q2 [细胞生物学];
学科分类号：
071009 ; 090102 ;
摘要：
引用
收藏
页码：A1 / A1
页数：1
相关论文
共 50 条
  • [21] Safety and efficacy of the conversion from calcineurin inhibitors to everolimus in heart transplant recipients a long-term single center observational study
    Capettini, A. C.
    Cannito, A.
    Greco, A.
    Pavesi, C.
    Pellegrini, C.
    D'Armini, A. M.
    Goggi, C.
    Raineri, C.
    Scelsi, L.
    Ghio, S.
    Visconti, L. Oltrona
    EUROPEAN HEART JOURNAL, 2016, 37 : 455 - 455
  • [22] mTOR inhibitors in kidney transplant recipients: long-term efficacy and discontinuation causes
    Cassia, Matthias
    Cacho, Judit
    Vergara Perez, Hugo
    Torres Jaramillo, Maria Veronica
    Alberici, Federico
    Diekmann, Fritz
    Cucchiari, David
    NEPHROLOGY DIALYSIS TRANSPLANTATION, 2024, 39 : I1625 - I1626
  • [23] mTOR inhibitors in kidney transplant recipients: long-term efficacy and discontinuation causes
    Cassia, Matthias
    Cacho, Judit
    Perez, Hugo Vergara
    Jaramillo, Maria Veronica Torres
    Alberici, Federico
    Diekmann, Fritz
    Cucchiari, David
    NEPHROLOGY DIALYSIS TRANSPLANTATION, 2024, 39
  • [24] CARDIOVASCULAR RISK IN KIDNEY TRANSPLANT RECIPIENTS RECEIVING mTOR INHIBITORS
    Watorek, Ewa
    Szymczak, Maciej
    Boratynska, Maria
    Patrzalek, Dariusz
    Klinger, Marian
    TRANSPLANT INTERNATIONAL, 2011, 24 : 118 - 118
  • [25] Clinical Experience of Late Conversion From Antimetabolites With Standard Exposure Calcineurin Inhibitors to Everolimus With Calcineurin Inhibitor Minimization in Stable Kidney Transplant Recipients With Good Renal Function
    Uchida, J.
    Iwai, T.
    Kuwabara, N.
    Kabei, K.
    Nishide, S.
    Yamasaki, T.
    Naganuma, T.
    Kumada, N.
    Takemoto, Y.
    Nakatanti, T.
    TRANSPLANTATION PROCEEDINGS, 2016, 48 (03) : 775 - 780
  • [26] Conversion from calcineurin inhibitors to mycophenolate mofetil in liver transplant recipients with diabetes mellitus
    Herrero, JI
    Quiroga, J
    Sangro, B
    Pardo, F
    Rotellar, F
    Cienfuegos, JA
    Prieto, J
    TRANSPLANTATION PROCEEDINGS, 2003, 35 (05) : 1877 - 1879
  • [27] Increased Incidence of Angioedema with ACE Inhibitors in Combination with mTOR Inhibitors in Kidney Transplant Recipients
    Duerr, Michael
    Glander, Petra
    Diekmann, Fritz
    Dragun, Duska
    Neumayer, Hans-H.
    Budde, Klemens
    CLINICAL JOURNAL OF THE AMERICAN SOCIETY OF NEPHROLOGY, 2010, 5 (04): : 703 - 708
  • [28] Associations between calcineurin inhibitors and arterial compliance in kidney transplant recipients
    Wystrychowski, Grzegorz
    Chudek, Jerzy
    Zukowska-Szczechowska, Ewa
    Wiecek, Andrzej
    Grzeszczak, Wladyslaw
    JOURNAL OF NEPHROLOGY, 2008, 21 (01) : 81 - 92
  • [29] THE EFFECT OF CALCINEURIN INHIBITORS ON ADIPOCYTOKINES AND NECK CIRCUMFERENCE IN KIDNEY TRANSPLANT RECIPIENTS
    Ersoy, Alparslan
    Koca, Nizameddin
    Koca, Tuba Gullu
    Kirhan, Emine
    Sarandol, Emre
    Ersoy, Canan
    Dirican, Melahat
    NEPHROLOGY DIALYSIS TRANSPLANTATION, 2013, 28 : 504 - 505
  • [30] Calcineurin and mTOR inhibitors in kidney transplantation: integrative metamodeling on transplant survival and kidney function
    Khalid, Hina
    Fareed, Muhammad Mazhar
    Dandekar, Thomas
    Shityakov, Sergey
    INTERNATIONAL UROLOGY AND NEPHROLOGY, 2024, 56 (04) : 1403 - 1414
12345